These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 695865)

  • 1. [Hypotonic orthostatic regulation disorders. Comparison of dihydroergotamine preparations with varying release of effective substances in the management of hypotonic orthostatic regulation disorders].
    Beck J; Schwaiger H
    ZFA (Stuttgart); 1978 Oct; 54(28):1454-9. PubMed ID: 695865
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of orthostatic circulatory lability. Oral dihydroergotamine in various galenic preparations in comparative studies on orthostasis reactions].
    Kayser-Petersen E
    Fortschr Med; 1978 Jul; 96(25):1339-42. PubMed ID: 669523
    [No Abstract]   [Full Text] [Related]  

  • 3. [What is the value of therapy with dihydroergotamine plus etilefrin in orthostatic circulation disorders].
    Schardt F
    Med Welt; 1981 Feb; 32(6):194-8. PubMed ID: 6110159
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hypotonic cardiovascular regulation disorders with amezinium (Regulton) and dihydroergotamine].
    Bückert C
    Fortschr Med; 1981 Aug; 99(30):1202-6. PubMed ID: 7024066
    [No Abstract]   [Full Text] [Related]  

  • 5. [Abnormalities of hypotonic orthostatic regulation: cardiovascular effects of dihydroergotamine, etilefrine and their combination (author's transl)].
    Gemeinhardt S; Schardt F; Polzien P
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1095-9. PubMed ID: 6114845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled comparison of dihydroergotamine and etilofrin in orthostatic syndrome].
    Garbe WE; Clasen J
    Med Welt; 1978 Jun; 29(22):939-42. PubMed ID: 26009
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dihydroergot plus in the long-term therapy of orthostatic hypotonic dysregulation in older patients].
    Muth HH; Jansen W
    Fortschr Med; 1980 Oct; 98(40):1571-4. PubMed ID: 6109687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effects of etilefrin and dihydroergotamine in management of the orthostatic syndrome].
    ZFA (Stuttgart); 1979 Mar; 55(8):545-8. PubMed ID: 34284
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydroergotamine therapy in orthostatic hypotension due to psychotropic drugs.
    Thulesius O; Berlin E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):465-7. PubMed ID: 2877953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of hypotonic circulation disorders].
    Schardt F; Gross W
    ZFA (Stuttgart); 1980 Nov; 56(33):2326-30. PubMed ID: 6110294
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of dihydroergotamine in severe orthostatic hypotension. 16 cases].
    Saïd G
    Presse Med; 1987 May; 16(17):800-3. PubMed ID: 2954090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of dihydroergotamine in the prevention and treatment of orthostatic hypotension syndromes in patients with parkinsonism treated with L-dopa].
    Jubert Gruart J; Balcells Riba M
    Arch Neurobiol (Madr); 1974; 37(4):401-12. PubMed ID: 4433212
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hypotonic circulation disorders].
    Heinrich JH
    Z Allgemeinmed; 1971 Sep; 47(26):1342-4. PubMed ID: 5097361
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cerebral orthostatic hypotension (author's transl)].
    Felgenhauer WR
    Schweiz Rundsch Med Prax; 1976 Oct; 65(43):1336-41. PubMed ID: 1005327
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hypotensive circulatory dysregulation with a combination of dihydroergotamine and etilefrine (author's transl)].
    Bracharz H; Polzien P
    MMW Munch Med Wochenschr; 1981 Jan; 123(5):177-80. PubMed ID: 6110188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dihydergot in the treatment of orthostatic dysregulation].
    Mishra BR
    Fortschr Med; 1979 Sep; 97(33):1436-40. PubMed ID: 488888
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of orthostatic hypotension with dihydroergotamine.
    Jennings G; Esler M; Holmes R
    Br Med J; 1979 Aug; 2(6185):307. PubMed ID: 476438
    [No Abstract]   [Full Text] [Related]  

  • 18. [Orthostatic hypotension. An attempt to simplify diagnosis -- treatment with dihydergot in general practice(author's transl)].
    Probst G
    Schweiz Rundsch Med Prax; 1975 Jun; 64(23):730-4. PubMed ID: 1099574
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is a single dose of dihydroergotamine per day sufficient?].
    Jansen W; Enghofer E; Seibel K
    MMW Munch Med Wochenschr; 1983 Jun; 125(23):498-502. PubMed ID: 6410213
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of orthostatic dysregulation: dihydroergotamine and etilefrin as a combination compared to the monosubtances].
    Polzien P; Bracharz H
    Med Klin; 1980 Dec; 75(25):878-82. PubMed ID: 6110162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.